Moreover, differences in outcome reporting, such as the use of absolute versus relative changes, or inconsistent definitions of endpoints like visceral adiposity or insulin resistance, further limited the ability to standardize data extraction and synthesis
This level of weight loss is associated with meaningful health benefits, including improvements in blood pressure, cholesterol levels, and blood sugar control, especially for individuals with prediabetes or type 2 diabetes
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand name Ozempic) and chronic weight management (as Wegovy)
Studies suggest that 20 50% of the total weight loss in individuals using semaglutide is due to muscle mass reduction, which is particularly evident in those with significant initial body weight
This means that even if you take 1000 mg or more, your body may only be absorbing a tiny fraction of that amount